Valeant Securities Fraud Case Lives, Could Lose Debt Claims
A New Jersey federal judge allowed a multibillion-dollar securities class action against Valeant Pharmaceuticals International Inc. and its top officials to move forward on Friday, although claims related to $15 billion...To view the full article, register now.
Already a subscriber? Click here to view full article